Brief: Stoke Therapeutics And Biogen Present Data That Further Support The Disease-Modifying Potential Of Zorevunersen
05/12/2025 14:11
Dec 5 (Reuters) - Biogen Inc BIIB.O: STOKE THERAPEUTICS AND BIOGEN PRESENT DATA THAT FURTHER SUPPORT THE DISEASE-MODIFYING POTENTIAL OF ZOREVUNERSEN, AN INVESTIGATIONAL MEDICINE FOR THE TREATMENT OF DRAVET SYNDROME, AT THE 2025 AMERICAN EPILEPSY SOCIETY (AES) ANNUAL MEETING Source text: ID:nBw8vnYtra Further company coverage: BIIB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stoke Therapeutics
See all newsBrief: Stoke Therapeutics Announces Inducement Grants
U.S. STOCKS ON THE MOVE-Moderna, O-I Glass, Aveanna Healthcare
U.S. STOCKS ON THE MOVE-NetEase, Werewolf Therapeutics, JP Morgan
U.S. STOCKS ON THE MOVE-Ubiquiti, BJ's Wholesale, Arbutus
U.S. STOCKS ON THE MOVE-Gold miners, Ross Stores, Stoke Therapeutics